Creotech Instruments stock
CRI.WAWSECreotech Instruments S.A., IndustrialsISIN PLCRTCH00017
60Score 60 out of 100, Neutral
Price and trend
59 / 100
Price history
+94% in one yearThe chart shows daily closes over 5 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 3.8% above it.
Since February 2025 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 33).
The price is 27% below its 52-week high. Largest decline in 5 years: 56% (April 2022 to February 2023).
Chart figures for advanced users
- SMA 50$200.14
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$183.79
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)33
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$88.07
- The lowest closing price of the last twelve months.
- Resistance$261.19
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Creotech Instruments S.A. belongs to the Aerospace & Defense industry (Poland) and, with a market value of $668.39M, is number 102 of 114 companies in its industry on MEQIRI.
- MEQIRI Score 60 out of 100 (Neutral): rank 540 of 1025 in Industrials, median 61.
- The P/E is 129.8 (Aerospace & Defense median 32.1, own median of recent years 76.8).
Show more
- Our model puts fair value at $66.23, with the price 199% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- High return on capitalReturn on invested capital 23.8% in fiscal 2025, Aerospace & Defense median 6.4%.Profitability 72
- More cash than debtCash $7.39M, financial debt $6.04M.Stability 67
Weaknesses
- DilutionShare count up 71% since 2020.Capital allocation 52
- Above fair valuePrice 199% above the fair value of $66.23.Valuation 16
- Richly valuedP/E 129.8, Aerospace & Defense median 32.1, own median 76.8.Valuation 16
Its standout strengths are profitability and momentum, while valuation holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high price swings
- price up very strongly over the past year
Valuation
Valuation signal
Significantly overvaluedClosing price of 10 Nov 2026, used by the daily score.
In our model the price counts as cheap below $44.15 and expensive above $132.46 (uncertainty very high, based on the price swings of the past year).
The two parts of the fair value come to $85.37 (cash-flow model) and $47.09 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 10.8%. At 11.8% the fair value would be $59.06, at 9.8% it would be $76.83.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (32.1).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
From 2025 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 14%, operating 13%, net not measured. From 2025 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 2 Dec 2026in 19 days
- Last reported
- 28 Sep 2026EPS reported $0.80
Analyst estimates
Earnings estimates have barely changed since 28 Oct 2026.
- Earnings per share
- $2.290.0%
- Revenue
- $66.6M0.0%
- Earnings per share
- $4.500.0%
- Revenue
- $107.19M0.0%
MEQIRI has stored the estimates since 28 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Creotech Instruments
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1025 rated companies in Industrials
- This company
- 60
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Aerospace & Defense
The next larger and next smaller companies by market value
- York Space SystemsYSS $994.47M41
- Sturm, RugerRGR $843.81M57
- FACCFACC.VI $724.52M57
- Smith & Wesson BrandsSWBI $709.81M56
- AevexAVEX $684.99M57
- Eve HoldingEVEX $672.6M30
- Red Cat HoldingsRCAT $655.14M31
- Elmet GroupELMT $644.19M39
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = PLN 3.9742)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 May 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.